Lobe科学称Mirza Rahimani CFO,自2026年3月2日起生效。 Lobe Sciences names Mirza Rahimani CFO, effective March 2, 2026.

位于佛罗里达的一家加拿大生物制药公司Lobe Science Ltd.,任命CA的CPA Mirza Rahimani为新的首席财务官,自2026年3月2日起生效。 Lobe Sciences Ltd., a Canadian biopharmaceutical company based in Florida, appointed Mirza Rahimani, CPA, CA, as its new Chief Financial Officer effective March 2, 2026. Rahimani自2025年12月1日起担任财务顾问,在金融、会计和公司治理方面积累了15年多的经验,具有生命科学、技术和采矿部门的专门知识。 Rahimani, who had served as a financial advisor since December 1, 2025, brings over 15 years of experience in finance, accounting, and corporate governance, with expertise in life sciences, technology, and mining sectors. 他接替了Yong Yao, 他曾通过与世纪生物实验室公司的一项安排提供服务。 He succeeds Yong Yao, who served through an arrangement with Century Biolabs Inc. 该公司侧重于推进对医疗需求未得到满足的疾病的治疗,强调公告中的某些声明具有前瞻性,涉及风险。 The company, focused on advancing therapies for diseases with unmet medical needs, emphasized that certain statements in the announcement are forward-looking and involve risks.